Preparation, evaluation and bioavailability studies of indomethacin-bees wax microspheres

Journal of Materials Science: Materials in Medicine

Volumn 20, Issue 7, 2009, Pages 1447-1456

  Gowda, D V ^a   Ravi, Valluru ^a   Shivakumar, H G ^a   Hatna, Siddaramaiah ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b SRI JAYACHAMARAJENDRA COLLEGE OF ENGINEERING   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOAVAILABILITY STUDY; CONTROLLED RELEASE; CROSS OVER; IN-VITRO; INDOMETHACIN; MODEL DRUGS; PHARMACOKINETIC PARAMETERS; SEM; SEM IMAGE; SINGLE-DOSE; SIZE RANGES; SPHERICAL SHAPE;

BIOCHEMISTRY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PRODUCTS; EMULSIFICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PHARMACOKINETICS; SCANNING; SCANNING ELECTRON MICROSCOPY; WAXES;

MICROSPHERES;

INDOMETACIN; MICROCID SR; MICROSPHERE; POLYSORBATE 80; PROPOLIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEEP; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; FEMALE; INDOMETHACIN; MALE; MICROSPHERES; SHEEP; WAXES;

APOIDEA;

EID: 67649083660     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-009-3710-8     Document Type: Article

References (21)

1. DV Gowda HG Shivakumar 2007 Encapsulation of theophylline into waxes /fat microspheres, preparation, characterization & release kinetics Hamdard Med 50 69 81
2. SH Chao AB Wu CJ Lee F Anchen CC Wang 2005 Anti-inflammatory effects of indomethacin's methyl ester derivative and induction of apoptosis in HL-60 cells Biol Pharm Bull 28 2206 2210 10.1248/bpb.28.2206
3. M Bogdan A Pirnau C Floare C Bugeal 2008 Binding interaction of indomethacin with human serum albumin J Pharm Biomed Anal 47 981 984 10.1016/j.jpba.2008.04.003
4. M Amir S Kumar 2005 Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives Arch Pharm (Weinheim) 338 24 8 10.1002/ardp.200400891
5. S Tamilvanan B Sa 2000 Studies on in vitro release behaviour of indomethacin loaded polystyrene microparticles Int J Pharm 201 187 97
6. DM Myers K Wilson DG Palmer 2005 An objective measurement of change in morning stiffness Rheumatol Int 1 135 40 10.1007/BF00541258
7. S Salib S Donney D Doyle 1996 Therapy and drugs in the control of osteoarthritis Prescr 8 41 59
8. DV Gowda HG Shivakumar 2007 Preparation and evaluation of waxes/fat microspheres loaded with lithium carbonate for controlled release Indian J Pharm Sci 69 251 256
9. LI Giannola V de Caro A Severoino 1995 Carnauba wax microspheres loaded with valproic acid: preparation and evaluation of drug release Drug Dev Ind Pharm 21 1563 1572 10.3109/03639049509069246
10. DV Gowda HG Shivakumar 2005 Encapsulation of griseofulvin in waxes/fat microspheres: preparation, characterization and release kinetics of microspheres Indian Drugs 42 453 460
11. DV Gowda HG Shivakumar 2006 Comparative bioavailability studies of indomethacin from two-controlled release formulations in healthy albino sheep Indian J Pharm Sci 68 760 763 (Pubitemid 46457274)
12. AG Johnson JE Roy 1992 Improved HPLC method for the determination of indomethacin in plasma Ther Drug Monit 14 61 5 10.1097/00007691-199202000-00010
13. United State Pharmacopoeia24/National formulary/19. Rockville: United State Pharmacopoeal Convention, 1999, p. 399.
14. Brien OM, Mccnndly J, Cohen E. In: Florey K, editor. Analytical profiles of drug substances, vol. 13. New York: American Academic Press; 1979. p. 222.
15. BS Nath Venkatesh D Hiremath 2000 Formulation and evaluation of sustained release dosage form of theophylline using a combined hydrophobic and hydrophilicmatrix Indian J Pharm Sci 62 33 36 (Pubitemid 30126422)
16. PL Ritger NA Peppas 1987 A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J Control Release 5 37 42 10.1016/0168-3659(87)90035-6
17. J Blanchard 1981 Evaluation of the relative efficacy of various techniques for deproteinising samplesprior to high-performance liquid chromatographic analysis J Chromatgr 226 455 460
18. E Pascual F Sivera 2007 Therapeutics in gout Curr Opin Rheumatol 19 122 127 10.1097/BOR.0b013e32802106b9
19. Food and Drug administration, Division of Biopharmaceutics. Bioavailability and NDA submission regulations, 1977.
20. D Brockmeir 1986 In vitro-in vivo correlation using movements of dissolution and transist time Acta Pharmacol Technol 32 16 23
21. FDA guidelines for industry 1997 Extended release oral dosage form evaluation and application for in vitro-in vivo correlations Dissol Tech 1 23 31